A carregar...
Armored CAR T-Cells: The Next Chapter in T-Cell Cancer Immunotherapy
Chimeric antigen receptor (CAR) T-cell therapy engineers T-cells to express a synthetic receptor which redirects effector function to the tumor, to improve efficacy and reduce toxicities associated with conventional treatments, such as radiotherapy and chemotherapy. This approach has proved effectiv...
Na minha lista:
| Publicado no: | Biologics |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8053711/ https://ncbi.nlm.nih.gov/pubmed/33883875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S291768 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|